Effects of General Medical Health on Alzheimer Progression: the Cache County Dementia Progression Study

Leoutsakos, Jeannie-Marie S.; Han, Dingfen; Mielke, Michelle M.; Forrester, Sarah N.; Tschanz, JoAnn T.; Corcoran, Chris D.; Green, Robert C.; Norton, Maria C.; Welsh-Bohmer, Kathleen A.; Lyketsos, Constantine G.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Effects of General Medical Health on Alzheimer Progression: the Cache County Dementia Progression Study

Published Date:

Jun 12 2012

Source:

Int Psychogeriatr. 24(10):1561-1570.

[PDF-306.03 KB]

Details:

Personal Authors:

Leoutsakos, Jeannie-Marie S. ; Han, Dingfen ; Mielke, Michelle M. ; Forrester, Sarah N. ; Tschanz, JoAnn T. ; ... More ▼

Keywords:

[+]

Pubmed ID:

22687143

Pubmed Central ID:

PMC3573852

Description:

Background

Several observational studies suggested a link between health status and rate of decline among individuals with Alzheimer’s disease (AD). We sought to quantify the relationship in a population-based study of incident AD, and to compare global comorbidity ratings to counts of comorbid conditions and medications as predictors of AD progression.

Methods

Results

Health Status tended to fluctuate over time within individuals. None of the baseline medical variables (GMHR, comorbidities, non-psychiatric medications) were associated with differences in rates of decline in longitudinal linear mixed effects models. Over time, low GMHR ratings, but not comorbidities or medications, were associated with poorer outcomes (MMSE: β=−1.07 p=0.01; CDR-sb: β=1.79 p<0.001; NPI: β=4.57 p=0.01)

Conclusions

Given that time-varying GMHR, but not baseline GMHR, was associated with the outcomes, there is likely a dynamic relationship between medical and cognitive health. GMHR is a more sensitive measure of health than simple counts of comorbidities or medications. Since health status is a potentially modifiable risk factor, further study is warranted.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

Supporting Files:

nihms-427930.nxml

application/octet-stream

No Related Documents.

You May Also Like:

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer’s disease

Personal Author:

Rosenberg, P. B.; Mielke, M. M.; Han, D.; Leoutsakos, J. S.; Lyketsos, C. G.; Rabins, P. V.; Zandi, P. P.; Breitner, J. C. S.; Norton, M. C.; Welsh-Bohmer, K. A.; Zuckerman, I. H.; Rattinger, G. B.; Green, R. C.; Corcoran, C.; Tschanz, J. T.;

Published:

Feb 29 2012

Source:

Int J Geriatr Psychiatry. 2011; 27(12):1248-1257.

Description:

Objective : The use of psychotropic medications in Alzheimer’s disease (AD) has been associated with both deleterious and potentially beneficial outcomes. We examined the longitudinal association of psychotropic medication use with cognitive, funct...

File Type:

[PDF - 401.07 KB]
Dementia and Its Implications for Public Health

Personal Author:

Chapman, Daniel P; Marshall Williams, Sheree; Strine, Tara W; Anda, Robert F; Moore, Margaret J;

Published:

Mar 15 2006

Source:

Prev Chronic Dis. 2006; 3(2).

Description:

Introduction : With the aging of the U.S. population, a better understanding of the presentation and impact of dementia is essential to the future of public health. Dementia refers not to a single disorder but to a number of syndromes characterized b...

File Type:

[PDF - 386.23 KB]
CETP Genotype Modifies the Effect of Apolipoprotein ε4 on Memory Decline in Older Adults

Personal Author:

Sundermann, EE; Wang, C; Katz, M; Zimmerman, ME; Derby, CA; Hall, CB; Ozelius, LJ; Lipton, RB;

Published:

Feb 16 2016

Source:

Neurobiol Aging. 41:200.e7-200.e12.

Description:

Apolipoprotein ε4 (ApoE4) is a strong genetic risk factor for sporadic Alzheimer's disease and memory decline in older adults. A single-nucleotide polymorphism in the cholesteryl ester transfer protein (CETP) gene (isoleucine to valine; V405) is ass...

File Type:

[PDF - 628.17 KB]
A Public health approach to Alzheimer's and other dementias. Module 1:Alzheimer's disease as a public health crisis

Corporate Author:

Alzheimer's Association. Centers for Disease Control and Prevention (U.S.). Rollins School of Public Health..

Published:

10/13/17

Series:

Public health approach to Alzheimer's and other dementias

Description:

This module is part of the Alzheimer’s Association curriculum, A Public Health Approach to Alzheimer’s and Other Dementias. Developed as part of a cooperative agreement with CDC’s Healthy Aging Program, and in partnership with Emory University�...

File Type:

[PDF - 3.82 MB]
A Public health approach to Alzheimer's and other dementias. Module 2:Alzheimer's and other dementias-the basics

Corporate Author:

Alzheimer's Association. Centers for Disease Control and Prevention (U.S.). Rollins School of Public Health..

Published:

10/13/17

Series:

Public health approach to Alzheimer's and other dementias

Description:

This module is part of the Alzheimer’s Association curriculum, A Public Health Approach to Alzheimer’s and Other Dementias. Developed as part of a cooperative agreement with CDC’s Healthy Aging Program, and in partnership with Emory University�...

File Type:

[PDF - 3.02 MB]